SU1181551A3 - Способ получени производных 3-хлорпрегнана - Google Patents
Способ получени производных 3-хлорпрегнана Download PDFInfo
- Publication number
- SU1181551A3 SU1181551A3 SU823505873A SU3505873A SU1181551A3 SU 1181551 A3 SU1181551 A3 SU 1181551A3 SU 823505873 A SU823505873 A SU 823505873A SU 3505873 A SU3505873 A SU 3505873A SU 1181551 A3 SU1181551 A3 SU 1181551A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- general formula
- acetonide
- chloro
- pregna
- water
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- RCRPCSZLUSZXST-PYASFRJRSA-N (8s,9s,10s,13r,14s,17s)-3-chloro-17-ethyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical class C1CC2CC(Cl)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 RCRPCSZLUSZXST-PYASFRJRSA-N 0.000 title claims description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims abstract description 6
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 claims abstract description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- QKZHYYBXLJMLNM-UHFFFAOYSA-N methanimidoyl chloride Chemical class ClC=N QKZHYYBXLJMLNM-UHFFFAOYSA-N 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 claims 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 239000000010 aprotic solvent Substances 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003862 glucocorticoid Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001448862 Croton Species 0.000 description 1
- 102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 102000016540 Tyrosine aminotransferases Human genes 0.000 description 1
- 108010042606 Tyrosine transaminase Proteins 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- NKCVNYJQLIWBHK-UHFFFAOYSA-N carbonodiperoxoic acid Chemical compound OOC(=O)OO NKCVNYJQLIWBHK-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-M chloroacetate Chemical compound [O-]C(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-M 0.000 description 1
- 229940089960 chloroacetate Drugs 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU812976A HU182775B (en) | 1981-10-15 | 1981-10-15 | Process for preparing new 3-chloro-pregnane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1181551A3 true SU1181551A3 (ru) | 1985-09-23 |
Family
ID=10961967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU823505873A SU1181551A3 (ru) | 1981-10-15 | 1982-10-15 | Способ получени производных 3-хлорпрегнана |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4456601A (enExample) |
| EP (1) | EP0077541B1 (enExample) |
| JP (1) | JPS5899500A (enExample) |
| AT (1) | ATE13676T1 (enExample) |
| AU (1) | AU550441B2 (enExample) |
| CA (1) | CA1202299A (enExample) |
| CS (1) | CS232737B2 (enExample) |
| DD (1) | DD204096A5 (enExample) |
| DE (1) | DE3264070D1 (enExample) |
| HU (1) | HU182775B (enExample) |
| IL (1) | IL67000A0 (enExample) |
| MX (1) | MX157221A (enExample) |
| PL (1) | PL131232B1 (enExample) |
| SU (1) | SU1181551A3 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8403905D0 (sv) * | 1984-07-30 | 1984-07-30 | Draco Ab | Liposomes and steroid esters |
| HU203769B (en) * | 1989-03-09 | 1991-09-30 | Richter Gedeon Vegyeszet | Process for producing new steroide derivatives and pharmaceutical compositions containing them |
| FR2695826B1 (fr) * | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
| PL309402A1 (en) * | 1992-12-24 | 1995-10-02 | Rhone Poulenc Rorer Ltd | Novel steroides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2990401A (en) * | 1958-06-18 | 1961-06-27 | American Cyanamid Co | 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids |
| US2985652A (en) * | 1958-06-17 | 1961-05-23 | Syntex Sa | 3-enol esters of 6-halo-16alpha-hydroxy cortical hormones |
| NL187577C (nl) * | 1978-04-05 | 1991-11-18 | Sibla Srl | 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen. |
-
1981
- 1981-10-15 HU HU812976A patent/HU182775B/hu not_active IP Right Cessation
-
1982
- 1982-10-14 US US06/434,335 patent/US4456601A/en not_active Expired - Fee Related
- 1982-10-14 AU AU89380/82A patent/AU550441B2/en not_active Ceased
- 1982-10-15 MX MX194824A patent/MX157221A/es unknown
- 1982-10-15 AT AT82109551T patent/ATE13676T1/de active
- 1982-10-15 CS CS827364A patent/CS232737B2/cs unknown
- 1982-10-15 DE DE8282109551T patent/DE3264070D1/de not_active Expired
- 1982-10-15 PL PL1982238641A patent/PL131232B1/pl unknown
- 1982-10-15 JP JP57181219A patent/JPS5899500A/ja active Granted
- 1982-10-15 SU SU823505873A patent/SU1181551A3/ru active
- 1982-10-15 CA CA000413492A patent/CA1202299A/en not_active Expired
- 1982-10-15 IL IL67000A patent/IL67000A0/xx not_active IP Right Cessation
- 1982-10-15 DD DD82244042A patent/DD204096A5/de not_active IP Right Cessation
- 1982-10-15 EP EP82109551A patent/EP0077541B1/de not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| J. Fried and J.A. Edwards. Organic Reactions in Steroid Chemistry, van Nostrand Reinhold Co, 1972, p. 394. * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5899500A (ja) | 1983-06-13 |
| AU550441B2 (en) | 1986-03-20 |
| CA1202299A (en) | 1986-03-25 |
| DE3264070D1 (en) | 1985-07-11 |
| HU182775B (en) | 1984-03-28 |
| ATE13676T1 (de) | 1985-06-15 |
| CS232737B2 (en) | 1985-02-14 |
| MX157221A (es) | 1988-11-04 |
| AU8938082A (en) | 1983-04-21 |
| US4456601A (en) | 1984-06-26 |
| PL238641A1 (en) | 1983-05-23 |
| IL67000A0 (en) | 1983-02-23 |
| DD204096A5 (de) | 1983-11-16 |
| PL131232B1 (en) | 1984-10-31 |
| EP0077541A1 (de) | 1983-04-27 |
| JPH0121840B2 (enExample) | 1989-04-24 |
| CS736482A2 (en) | 1984-06-18 |
| EP0077541B1 (de) | 1985-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5410040A (en) | Diamino-androstane derivatives | |
| SU613724A3 (ru) | Способ получени 8-тиометил-эрголинов или их солей | |
| US4588528A (en) | 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same | |
| SU1181551A3 (ru) | Способ получени производных 3-хлорпрегнана | |
| JP3734090B2 (ja) | 新規シリル化合物およびその使用 | |
| SU581869A3 (ru) | Способ получени производных ксантена | |
| EP0203435B1 (en) | Novel pyridine derivatives and process for preparing the same | |
| EP0197390B1 (en) | Preparation of n-acetyl serotonine and melatonine | |
| SU797585A3 (ru) | Способ получени сложных эфиров геста-гЕНОВ | |
| US2864834A (en) | Pregnatetraenes and method of preparing the same | |
| US4217288A (en) | Anti-vitamin D compounds | |
| EP0056000A2 (fr) | Dérivés 17/(alkoxycarbonyle) (formamido) méthylène/stéroides et leur préparation | |
| SU688129A3 (ru) | Способ получени имидазо-изохинолиндионов или их солей | |
| NO128533B (enExample) | ||
| SU890979A3 (ru) | Способ получени кортикоидов | |
| EP0231671B1 (en) | Gonatriene derivatives and process for preparing them | |
| SU852176A3 (ru) | Способ получени производных стероид-СпиРО-ОКСАзОлидиНОНА | |
| NO128608B (enExample) | ||
| JPH07121944B2 (ja) | Ｎ▲下１▼‐メチル‐１０α‐メトキシルミリセルゴールの製造方法 | |
| US4217279A (en) | Synthesis of steroids | |
| KR890003840B1 (ko) | 8-할로-5, 6-디알콜시퀴나졸린-2, 4-디온의 제조방법 | |
| US2985650A (en) | 6alpha-ammonio-derivatives of 11-keto cortical hormones | |
| US4304727A (en) | 9α-Debromination | |
| US4145357A (en) | Steroid derivatives and process for preparing the same | |
| SU722487A3 (ru) | Способ получени производных 3-амино-17а-аза- -гомо-5 - андростана или их солей, или их четвертичных солей |